NantBioScience Ties With University of Colorado

Los Angeles-based NantBioScience, one of the companies out of the NantWorks family of companies founded by billionaire Dr. Patrick Soon-Shiong, said this morning that it has tied with the University of Colorado on developing a protein cancer fighting drug. According to NantBioScience, it is in a research collaboration and an exclusive worldwide licensing agreement with the University of Colorado for the development and commercialization of anti-cancer agents. Financial details of the deal were not disclosed. The two said that both the University of Colorado and NantBioScience will be conducting research activities together.